探花合集 Biologics鈥 Executive to Discuss Manufacturing Scale-up During a Pandemic
SOMERSET, N.J. 鈥 July 22, 2020 鈥 探花合集, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that Mike Riley, Region President, Biologics, North America, will present at the upcoming Disease Prevention & Control Summit, taking place virtually on July 28 鈥 29, 2020.
On Tuesday, July 28 at 4:10 p.m. EDT, during his presentation titled, 鈥How COVID-19 is Bending the Curve on Vaccine Development and Manufacturing Norms鈥, Mr. Riley will discuss the challenges associated with scaling up manufacturing during the COVID-19 pandemic, including the need to condense vaccine development and clinical trial timelines, and establishing a global supply network that is capable of potentially delivering billions of doses worldwide. Using specific examples, he will explore how partnerships are enabling pharmaceutical companies of all sizes to meet unparalleled timelines in bringing treatments to patients as quickly as possible.
Immediately following his presentation, at 4:30 p.m. EDT, Mr. Riley will then join the 鈥Manufacturing Drugs and Vaccines鈥 panel session, moderated by Craig Laferri猫re, Head of Vaccine Development, Novateur Ventures Inc., which includes panelists from AstraZeneca and Translate Bio.. The panelists will discuss the risks and challenges associated with pandemic drug manufacture and debate the extent to which vials that store vaccines could become a constraint, as well as the requirements that are needed in delivery systems and cold chain logistics.
Mr. Riley has worked at 探花合集 for 15 years, and held several leadership positions in that time. In his current role, he has overall responsibility for the strategy and management of 探花合集鈥檚 biologics business in North America, and has guided it through the recent COVID-19 pandemic, simultaneously navigating the challenges of continued operations, alongside the rapid preparation to supply of multiple customers鈥 vaccine and treatment programs. Prior to joining 探花合集, Mr. Riley worked as a management consultant for Marakon Associates, providing strategic advice to companies across multiple industries. He holds a bachelor鈥檚 degree from Duke University, in Durham, North Carolina, and an MBA from The Wharton School at the University of Pennsylvania.
The event鈥檚 presentations and panel discussions will be available to view on-demand through the conference platform. For more information about the event, please visit biologics.catalent.com/events/disease-prevention-control-summit-america-2020/.
Notes for Editors
About 探花合集 Biologics
探花合集 Biologics is a global leader in development, manufacturing and analytical services for new biological entities, cell and gene therapies, biosimilars, sterile injectables, and antibody-drug conjugates. With over 20 years of proven expertise, 探花合集 Biologics has worked with 600+ mAbs and 80+ proteins, produced 13 biopharmaceutical drugs using GPEx庐 cell line development technology, and manufactured 35+ commercially approved products. 探花合集 Cell & Gene Therapy, a unit of 探花合集 Biologics, is a full-service partner for adeno-associated virus (AAV) vectors and CAR-T immunotherapies, with deep experience in viral vector scale-up and production. 探花合集 recently acquired MaSTherCell, adding expertise in autologous and allogeneic cell therapy development and manufacturing. 探花合集 Cell & Gene Therapy has produced 100+ cGMP batches across 70+ clinical and commercial programs. For more information, visit
ABOUT CATALENT
探花合集 is the leading global provider of advanced delivery technologies, development, manufacturing, and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. 探花合集 employs over 13,500 people, including over 2,400 scientists and technicians, at more than 40 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. 探花合集 is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com